COVID VACCINE INVESTING. Up to date information about the smaller bio-pharmaceutical companies developing a COVID vaccine. This blog features a COVID INVESTOR INDEX which keeps track of the relative performance of 28 key COVID VACCINE companies.
Wednesday, 17 March 2021
Tonix and Immunity Bio strong on relatively flat day
Tonix rockets ahead 18% while Immunity Bio gains 11%. Other strong performers include Vir and Onco Sec which had gains around 8%.
Overall, these stocks gained 1.4% on average with 16 gaining ground and ten losing.
IMV dropped 16% while Moderna gave back 5% as did Generex.
No comments:
Post a Comment